Patel Sujal M's Form 4 filing
Nautilus Biotechnology, Inc. (NAUT) · filed Sep 9, 2025
- Accession no.
- 0001378830-25-000003
- Filed
- Sep 9, 2025
- Trade date
- Sep 5-8, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $134.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patel Sujal MCIK 0001378830 | Director, Officer (CEO, President, and Secretary), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 5, 2025 | Common Stock | PPurchaseAcquired | +116,500 | $0.67 | +$78,055 | 10,258,221 | Direct | |
| Sep 8, 2025 | Common Stock | PPurchaseAcquired | +83,500 | $0.68 | +$56,780 | 10,341,721 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.